| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Departments of Pediatrics and Pathology, Women and Infants’ Hospital, and
Department of Medicine, Rhode Island Hospital-Brown University, Providence, RI 02905; and
Division of Neonatology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ 08903
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
neutralization, or IL-10 administration rescued pregnancy in LPS-treated IL-10–/– animals. Our results identify an immune mechanism of fetal demise involving IL-10 deficiency, NK cells, and inflammation. These results may provide insight into adverse pregnancy outcomes in humans. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
The maternal-fetal interface constitutes a unique environment for innate and adaptive immune responses (6, 7). However, the implanted embryo and developing fetus during normal pregnancy are capable of suppressing these immune responses (8). There also appear to be pregnancy-compatible alterations in the maternal immune system that protect against a graft-vs-host reaction from the fetal immune system (8). However, aberrant immune regulation may result in adverse pregnancy outcomes. In mice, disruptions in T cell regulation have been shown to result in immune-mediated loss of the fetal allograft (9, 10). In normal pregnancy, no adverse immune responses are mounted despite the presence of high numbers of uterine NK (uNK)3 cells (up to 65–70%) as well as smaller populations of macrophages, T cells, and other immune cells in the uterus during early stages of pregnancy (11). These cells populate the uterus after implantation in mice and during the proliferative stage of the menstrual cycle in humans, where they increase in number until midgestation. Thereafter, their numbers decline rapidly (11, 12). Most studies to date have shown a pregnancy-compatible role for uNK cells in reproduction, mainly through their regulation of decidualization, production of pregnancy-compatible cytokines, and cross-talk with the trophoblast. During pregnancy, NK cell-deficient mice display abnormalities in decidual artery remodeling and trophoblast invasion, possibly due to the lack of uNK cell-derived IFN-
(13, 14, 15, 16). In humans, it has been suggested that defective trophoblast invasion and placental development are associated with altered uNK cell function and preeclampsia (17, 18). Curiously, although uNK cells display an activated phenotype (19, 20), to date, no in vivo role for uNK cell cytotoxicity has been identified. It is tempting to propose that although uNK cells normally contribute to the success of pregnancy, they may exert a negative role given aberrant intrauterine conditions.
For the most part, tolerogenic processes that control the maternal immune system and protect the fetus are probably local and temporal at the maternal-fetal interface. The search for components of the intrauterine milieu that contribute to successful pregnancy outcome and control detrimental innate and adaptive inflammatory immune responses has implicated cytokines, neuroendocrine immunomodulators, complement regulators, and nutrition-based factors (9, 21, 22). Among cytokines, the anti-inflammatory cytokine IL-10 is especially attractive for a critical role in pregnancy because of its regulatory relationship with other intrauterine modulators and its wide range of immunosuppressive activities (23). Significantly, its local production by gestational tissues is well documented (24, 25, 26). We observed that IL-10 expression by the human placenta was gestational age dependent, with significant expression through the second trimester coupled with attenuation at term (26). IL-10 expression was also found to be poor in decidual and placental tissues from unexplained spontaneous abortion cases (27) and from deliveries associated with preterm labor and pre-eclampsia (our unpublished observations). However, the mechanism(s) by which IL-10 protects the fetus remains poorly understood. Although IL-10–/– mice suffer no pregnancy defects when mated under pathogen-free conditions (28), these mice eventually develop colitis and fail to control intrinsic inflammatory responses (29, 30). It is then plausible that in addition to IL-10 deficiency, an unregulated inflammatory insult resulting from genital tract infections, environmental factors, and/or hormonal anomalies during gestation may lead to adverse pregnancy outcomes.
A likely potential mechanism for IL-10-mediated protection of pregnancy is through direct action on decidual immune cells. In this study we demonstrate a novel regulatory relationship among IL-10 deficiency, inflammation, enhanced uNK cell activity, and pregnancy loss. Exposure of IL-10–/–, but not wild-type, mice to low doses of LPS provokes vigorous uNK cell cytotoxicity and invasiveness into the placental zone, leading to dose-dependant fetal demise or intrauterine growth restriction (IUGR). Immunodepletion of uNK cells, IL-10 administration, or treatment with anti-TNF- Ab, but not anti-IFN- Ab, reverses these LPS-induced pregnancy defects. Taken together, these results imply a crucial regulatory cross-talk between IL-10 and uNK cells in the prevention of inflammation-induced adverse pregnancy outcomes.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
The mice used in this study, C57BL/6, C57BL/6 IL-10–/–, NOD, and NOD IL-10–/–, were obtained from The Jackson Laboratory. All mice were housed in a specific pathogen-free facility supervised by the Central Research Department of Rhode Island Hospital. All protocols were approved by the Lifespan Animal Welfare Committee and conducted according to its guidelines.
In vivo treatments
Mice received i.p. injections of serotype 026:B6 Escherichia coli LPS (Sigma-Aldrich) at doses of 0.2, 0.5, or 1 µg/mouse on gestational day (gd) 6.5 or an equivalent volume (100 µl) of saline. For NK cell depletion, mice received i.p. LPS injections of 0.5 µg as described above and i.p. injection of rabbit anti-asialo-GM1 (100 µl; Wako USA) or anti-NK1.1 (PK-136; 250 µg; BD Biosciences) on gd 4, 6.5, and 9. Nonimmune rabbit serum (NRS; Antibodies, 100 µl) or irrelevant isotype Ab was injected in parallel as a control. IL-10 was administered i.p. in a single dose of 500 ng/mouse on gd 6.5 immediately before LPS administration. Anti-IFN- (XMG1.2) and anti-TNF- (G281-2626) mAbs (BD Biosciences) were administered i.p. at 750 and 300 µg, respectively, on gd 5 and 7 with LPS injection on gd 6.5.
Cell preparation
Uterine mononuclear cells (UMC) were obtained by mincing and mechanical dispersion of whole gd 10–13 uterus and placenta (containing entire uterus and placenta with fetus removed) in RPMI 1640 supplemented with 10% FBS, penicillin/streptomycin, and L-glutamine. Single-cell suspensions from uterine horns from three mice were pooled and subsequently subjected to density gradient separation using Fico-Lite LM (Atlanta Biologicals).
Flow cytometry
Isolated UMC were washed in PBS and resuspended in PBS containing 0.1% sodium azide and 1% BSA. FITC-conjugated anti-CD45 (30-511), PE-conjugated anti-NK1.1 (PK136), PerCP-conjugated anti-CD3 (145-2C11; BD Biosciences), and PerCP-conjugated anti-F4/80 (Serotec) were then added simultaneously and allowed to incubate at 4°C for 30 min. Fluorochome-conjugated isotype Abs of irrelevant specificity were used as controls.
Cytotoxicity assays
The uNK cell activity was measured using a standard chromium release assay as previously described (31) or using a flow cytometry-based system. Target YAC-1 cells (5 x 103) were labeled with 0.15 mCi of Na2(51CrO4) (PerkinElmer) for 1 h at 37°C. Effector UMC were added to target cells at descending half-fold E:T cell ratios of 50:1 to 1.56:1 in RPMI 1640 plus 10% FBS, and supernatants were harvested after an incubation of 5 h at 37°C in 10% CO2 and read on a gamma radiation counter. The percent lysis was calculated as: [(sample count – spontaneous release)/(maximal release – spontaneous release)] x 100. Spontaneous release was assessed by the radioactivity detected in the supernatant from target cells incubated alone, and maximal release was assessed by the radioactivity detected in the supernatant from target cells lysed with 1 N HCl. The flow cytometry-based cytotoxicity assay was performed according to the manufacturer’s protocol (Molecular Probes). Briefly, target cells were treated with 3,3'-dioctadecyloxacarbocyanine for 20 min at 37°C. Effector cells were mixed with target cells as described above, and propidium iodide was added to effector/target cell cultures, which were incubated for 2 h at 37°C in 10% CO2. Cellular events were then immediately acquired on a flow cytometer.
Histochemistry
Individual, intact utero-placental units were isolated and fixed with 10% buffered formalin for 24 h. Tissue was processed for histological staining with hematoxylin and periodic acid-Schiff reagent (PAS) as previously described (32)
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
We studied the effect of IL-10 on syngeneic and allogeneic pregnancies in a mouse model of IL-10 deficiency coupled with the inflammatory signal provided by LPS administration. Timed syngeneic matings between C57BL/6 IL-10–/– mice or allogeneic matings between female C57BL/6 IL-10–/– mice (H-2b) and male NOD IL-10–/– mice (H-2k) were conducted. Matings using congenic wild-type (IL-10+/+) mice were set up in parallel as a control for normal pregnancy outcome (Table I). In the preliminary experiments, LPS doses >1 µg/mouse were found to result in severe placental pathology in IL-10–/– mice. Thus, LPS doses of 0.5 or 0.2 µg/mouse have been used in all experiments. Pregnant mice were injected i.p. with 0.5 or 0.2 µg of LPS or saline (100 µl) on gd 6.5 as described in Materials and Methods. The mice were either killed on gd 10–13 and their uterine horns examined or were allowed to deliver. As shown in Table I, pregnancy progressed normally in matings of IL-10–/– mice in the absence of LPS treatment. At 0.5 µg of LPS/mouse, both allogeneically and syngeneically mated IL-10–/– mice experienced total fetal loss. However, at the same dose, pregnant wild-type mice had successful pregnancy with no resorptions. In addition, pregnancy in wild-type mice appeared unaffected even at a 10-fold higher dose (data not shown). The condition of the uterine horns of both wild-type and IL-10–/– mice receiving saline injections was consistent with normal pregnancy (Fig. 1). In contrast, although pregnancy was unaffected by administration of 0.5 µg of LPS/mouse in wild-type mice (Fig. 1), this dose resulted in fetal resorption with an obvious necrotic appearance in IL-10–/– mice. By comparison, injection of 0.2 µg of LPS/mouse in syngeneically mated IL-10–/– mice (n = 4) resulted in IUGR with no obvious resorption or necrosis (Fig. 1). Similar results were observed in allogeneic matings (data not shown). Our findings demonstrate that pregnancy in IL-10–/– mice is exceptionally sensitive to the detrimental effects of very low doses of LPS. Furthermore, the severity of the effect of LPS on pregnancy in these animals is dose dependent.
|
|
Although uNK cells appear to be primed for cytotoxic activity due to their abundant perforin-containing granules, they remain pregnancy compatible during normal gestation. Recent in vitro studies have suggested that human peripheral blood NK cells become cytotoxically activated and proliferate in response to LPS, and these responses are enhanced in the presence of anti-IL-10R-blocking Abs (33). Thus, uNK cells from LPS-treated mice were assessed for their natural killing activity. UMC were obtained on gd 10–13 from syngeneically mated C57BL/6 IL-10–/– or congenic wild-type mice that had received an i.p. dose of LPS at 0.5 µg/mouse or saline on gd 6.5 as described above. In response to LPS administration, the proportion of uNK (NK1.1+CD3–) cells as a percentage of the total immune cell (CD45+) population significantly increased in IL-10–/– mice (24.9–51.8%) in contrast to congenic wild-type mice (27.8–36.1%) (Fig. 2). Interestingly, at this dose of LPS, neither wild-type nor IL-10–/– splenic NK cells showed any increase (Fig. 2). LPS had little effect on the NK cytotoxicity of wild-type UMC, as measured by 51Cr release assay (Fig. 3A) or a flow cytometry-based method (data not shown) on NK cell-specific target YAC-1 cells, whereas cells from LPS-treated IL-10–/– mice acquired significant cytotoxic activity. Results from two allogeneic mating experiments were similar to those described above (data not shown). Splenic mononuclear cells from neither IL-10–/– nor wild-type mice displayed increased cytotoxicity in response to LPS, suggesting a selective effect on uNK cells of LPS administration (data not shown). Notably, UMC from animals receiving 0.2 µg of LPS/mouse displayed an intermediate NK cytotoxicity index between animals receiving 0.5 µg of LPS/mouse and animals receiving saline alone (Fig. 3B). Thus, the dose-dependant gross pathology observed in LPS-treated IL-10–/– mice is associated with a graded increase in uNK cell cytotoxic activity as well as an increase in the proportion of uNK cells.
|
|
Uterine NK cells are primarily localized to the mesometrial decidua in pregnant wild-type mice through gd 14 (13). At this time, trophoblast cells invade the mesometrial zone and replace uNK cells, which are normally absent from this region during later stages of pregnancy. To assess the role of uNK cells in the observed fetal demise, we examined the localization of these cells in response to LPS administration. The high carbohydrate content of the perforin-containing granules of uNK cells can be easily visualized by staining with PAS (32). Fixed uterine tissue from the syngeneically or allogeneically mated C57BL/6 IL-10–/– or wild-type congenic females (gd 10 or 12) was examined by PAS/hematoxylin staining. In wild-type mice, uNK cells were restricted to the mesometrial decidua in response to saline treatment, with no effect on their localization or migration after LPS treatment (Fig. 4). Similarly, uNK cells from IL-10–/– mice receiving saline injections also remained localized to the mesometrial decidua (see Fig. 6, A–D). In contrast, uNK cells from IL-10–/– mice treated with 0.5 µg of LPS/mouse began to accumulate at the decidua basalis (DB) by gd 10 (Fig. 5, A–D) and penetrated the labyrinth zone by gd 12 (Fig. 5, E–H). In gd 12 tissue, PAS-stained cells were quantitatively fewer. This is probably due to advanced placental pathology on gd 12 in response to LPS treatment (Fig. 5, E–H). Interestingly, upon administration of 0.2 µg of LPS/mouse, uNK cells invaded the DB region and the placental zone only by gd 13 (Fig. 6, E–H), with no apparent fetal pathology. This is consistent with the observation of a more moderate effect at this dose with resultant fetal growth restriction. It is thus possible that delayed penetration of uNK cells into the placenta may lead to IUGR or preterm delivery (our unpublished observations).
|
|
|
The increase in uNK cell cytotoxicity and invasiveness observed in LPS-treated IL-10–/– mice suggest a role for uNK cells in fetal demise. To examine this possibility, we conducted syngeneic matings as described above. In addition to injection of 0.5 µg of LPS/mouse on gd 6.5, we conducted NK cell depletion. Anti-asialo-GM1 Ab treatment has been widely used for in vivo NK cell depletion in mice. However, the asialo-GM1 Ag can be expressed on minor subpopulations of other immune cells. Thus, to delineate the specific role of uNK cells in pregnancy pathology, NK cell depletion was performed using either anti-asialo-GM1 polyclonal or anti-NK1.1 mAbs i.p. on gd 4, 6.5, and 9. NRS or irrelevant isotype control Ab was used in parallel as a control. Pregnant mice were then killed on gd 11–13, UMC were isolated, and some of the feto-placental units were fixed for histology. Both anti-asialo-GM1 and anti-NK1.1 treatments successfully depleted uNK cells, as demonstrated by the complete reduction in PAS-positive cells (data shown only for anti-asialo-GM1 treatment) in the uterus of treated animals (Fig. 7C). The successful depletion of uNK cells was also confirmed by flow cytometric demonstration of the reduction in the NK1.1+ population (Fig. 7A, top). Our data also demonstrate that collateral F4/80+ macrophage depletion did not occur as a result of NK cell depletion (Fig. 7A, bottom). Consistent with successful NK cell depletion, UMC NK cytotoxicity was shown to be abrogated after anti-asialo-GM1 or anti-NK1.1 depletion (Fig. 7B). These observations prompted us to assess the effect of NK cell depletion by both anti-asialo-GM1 and anti-NK1.1 treatment on pregnancy outcome in IL-10–/– mice. As shown in Fig. 8 and Table II, NK cell depletion by both Abs successfully rescued pregnancy in LPS-treated animals, implying that cytotoxic activation and placental migration of uNK cells contribute to fetal demise in the context of IL-10 deficiency.
|
|
|
neutralization abrogates LPS-induced fetal resorption in IL-10–/– mice
NK cell functions are mediated by cytokines such as IFN- and TNF- as well as by the perforin/granzyme cytotoxic pathway (14, 19, 34). The fact that NK cell depletion rescued pregnancy in LPS-treated IL-10–/– mice (Fig. 8 and Table II) prompted us to investigate the roles of IFN- and TNF- in LPS-induced fetal resorption by in vivo Ab-mediated neutralization of these cytokines as described in Materials and Methods. In parallel, mouse recombinant IL-10 was administered i.p. immediately before LPS administration. Examination of excised uterine horns on gd 11–13 revealed that IL-10 administration restored normal utero-placental unit morphology in LPS-treated mice, consistent with normal pregnancy (Fig. 8 and Table II). Interestingly, treatment with anti-IFN- mAb failed to restore pregnancy, whereas treatment with anti-TNF- mAb significantly reduced the number of fetal resorption sites (Fig. 8). This was confirmed by term delivery outcome by IL-10–/– mice in response to these treatments. These data suggest that TNF-, not IFN-, is likely to play a critical role in uNK-cell mediated LPS-induced fetal demise in IL-10–/– mice.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
The restoration of pregnancy in LPS-treated IL-10–/– mice upon NK cell depletion suggests that uNK cells are targets for LPS activity leading to fetal demise (Fig. 5). Several studies have shown LPS-mediated effects on NK cells. Treatment of in vitro cultures of isolated human PBMC with LPS induces the proliferation and cytotoxic activation of NK cells (33, 35). Additionally, IFN- responses to LPS administration are markedly reduced in NK cell-deficient mice (36). It is not entirely clear whether the NK cell functional effects of LPS treatment are direct or require accessory cells. Neither peripheral nor uNK cells express CD14, a major accessory LPS receptor. Likewise, NK cell expression of the LPS-signaling TLR4 has not been reported. As such, LPS may exert its effect on NK cells indirectly, perhaps through uterine macrophages, dendritic cells, or placental trophoblast cells. Indeed, the LPS-induced NK cell proliferation by human PBMCs appears to require dendritic cells (33), possibly via the induction of NK cell stimulatory cytokines. LPS has been shown to up-regulate the expression of IL-12 in placental trophoblast (37) as well as both IL-12 and IL-18 in macrophages (38, 39).
Our findings uniquely suggest that IL-10 may be a regulatory factor for uNK cells in the context of inflammation, as shown by rescue of pregnancy by this cytokine in LPS-treated IL-10–/– mice (Fig. 8 and Table II). The precise function of IL-10 in limiting uNK cell-induced pathology is unclear. IL-10 has been implicated in the control of LPS-induced NK cell proliferation in vitro (33). Moreover, IL-10 can inhibit the production of cytokines produced in response to LPS that enhance NK cell activity, such as IL-12 and TNF- (23). A possible explanation for the increased invasiveness of uNK cells in response to LPS in the absence of IL-10 may be through altered chemokine expression. LPS induces the expression of a variety of chemokines in macrophages (40), and this effect is antagonized by IL-10 (41, 42). LPS and IL-10 also exert antagonistic effects on the expression of matrix metalloproteinases (MMPs) in macrophages and trophoblasts. LPS induces the expression of MMPs (43, 44), whereas IL-10 inhibits expression of MMPs and induces the expression of tissue inhibitor of metalloproteinase (45, 46). Therefore, reduced IL-10 production could potentially lead to increased MMP expression in uNK cells, thus enhancing their invasiveness.
The influx of a large number of potentially cytotoxic NK cells into the uterus during pregnancy seems counterintuitive. In this regard, two major functions of uNK cells have been suggested in the context of pregnancy. Mice deficient in NK cells display defects in decidual spiral artery remodeling (32, 47), which appears to be due to the lack of uNK cell-derived IFN- production (48). However, NK cell-deficient mice show a normal pregnancy outcome. Another proposed uNK cell function is regulation of trophoblast invasion into the decidua. Recent evidence supporting this hypothesis demonstrates a reciprocal relationship between location of uNK cells and trophoblasts during gestation (13). IFN- is thought to play a major role in this process, because IFN- treatment inhibits trophoblast migration in placental explants. Although these studies suggest a temporal role for IFN- in reproduction, exogenous IFN- administration at high doses is known to result in fetal resorption in mice (49). However, IFN- does not appear to play a significant role in the fetal resorption observed in the IL-10–/– mouse model of LPS-induced pregnancy failure. Interestingly, NK cell-deficient mice are resistant to fetal loss due to systemic up-regulation of TNF- and reproductive endocrine dysfunction mediated by anti-CD40 Ab administration during early stages of pregnancy (50). In this regard, our data (Fig. 8 and Table II) clearly suggest that TNF- is a key cytokine leading to uNK cell-mediated fetal resorption. Consistent with this are our observations of an increase in TNF--producing, but not IFN--producing, CD45+ UMC from LPS-treated pregnant IL-10–/– mice (our unpublished observations). Macrophages are recruited at the maternal-fetal interface and are major producers of TNF- (51). As such, they would appear to be prime candidate cells responsible for the deleterious production of TNF- in response to LPS. However, because NK cell-depleted mice retain uterine macrophages (Fig. 7A, bottom) yet do not experience fetal resorption in response to LPS, it is unlikely that macrophage-derived TNF- is involved in the observed fetal demise. This does not, however, rule out a cross-talk between uterine macrophages and uNK cells, with the latter cells playing a dominant role. In addition, IL-10 administration can rescue pregnancy in LPS-treated IL-10–/– mice, suggesting that this potent anti-inflammatory cytokine can counteract pregnancy-incompatible activities of TNF- and cytotoxic uNK cells. We speculate that uNK cells, in addition to their well-studied role in decidualization, may serve as a fail-safe mechanism to terminate pregnancy when excessive inflammatory or other insults are experienced, sparing the mother from the energy waste of carrying a damaged or abnormal fetus.
The increase in cytotoxicity associated with fetal demise described in this study indicates a novel function for uNK cells in the inflammation-induced termination of pregnancy. During normal pregnancy, these cells may contribute to gestational success by contributing to the IL-10 pool and aiding in the remodeling of spiral arteries, whereas in response to inflammatory insults, they may contribute to the fetal demise or premature termination of pregnancy (our manuscript in preparation). Furthermore, we demonstrate that IL-10 plays a positive role in the protection of pregnancy from these effects. IL-10 may play a dual role of protecting trophoblast cells against apoptosis (our unpublished observations) as well as controlling the effects of TNF- and activated uNK cells. In humans, NK cell activity is increased in some women experiencing recurrent spontaneous abortion compared with that during normal pregnancy (52). Our findings suggest that an association among inflammation, poor IL-10 production, and cytotoxic uNK cell activation may explain the etiology of unexplained adverse pregnancy outcomes.
|
Acknowledgments |
|---|
|
Disclosures |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
|
Footnotes |
|---|
1 This work was supported by National Institutes of Health Grants HD41701 and P20RR018728 (to S.S.). 
2 Address correspondence and reprint requests to Dr. Surendra Sharma, Department of Pediatrics, 101 Dudley Street, Women and Infants’ Hospital of Rhode Island, Providence, RI 02905. E-mail address: ssharma{at}wihri.org
3 Abbreviations used in this paper: uNK, uterine NK; DB, deciduas basalis; gd, gestational day; IUGR, intrauterine growth restriction; MMP, matrix metalloproteinase; NRS, nonimmune rabbit serum; P, placental labyrinth; PAS, periodic acid-Schiff; UMC, uterine mononuclear cell.
Received for publication May 27, 2005. Accepted for publication July 11, 2005.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionDisclosuresReferences |
|---|
production during murine pregnancy. Semin. Immunol. 13:235.-241. [Medline]
production during murine pregnancy. Semin. Immunol. 3:235.-241.
production by T cells. Nature 378:88.-91. [Medline]
peptides, MIP-1 and MIP-1, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines -IFN, IL-10, IL-4, and TGF-. Mol. Med. 4:648.-657. [Medline]
contributes to the normalcy of murine pregnancy. Biol. Reprod. 61:493.-502. This article has been cited by other articles:
|
|
 |
|
  J. E. Thaxton, R. Romero, and S. Sharma TLR9 Activation Coupled to IL-10 Deficiency Induces Adverse Pregnancy Outcomes J. Immunol., July 15, 2009; 183(2): 1144 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tewari, S. Kalkunte, D. W. Murray, and S. Sharma The Water Channel Aquaporin 1 Is a Novel Molecular Target of Polychlorinated Biphenyls for in Utero Anomalies J. Biol. Chem., May 29, 2009; 284(22): 15224 - 15232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bizargity, R. Del Rio, M. Phillippe, C. Teuscher, and E. A. Bonney Resistance to Lipopolysaccharide-Induced Preterm Delivery Mediated by Regulatory T Cell Function in Mice Biol Reprod, May 1, 2009; 80(5): 874 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kalkunte, T. F. Mselle, W. E. Norris, C. R. Wira, C. L. Sentman, and S. Sharma Vascular Endothelial Growth Factor C Facilitates Immune Tolerance and Endovascular Activity of Human Uterine NK Cells at the Maternal-Fetal Interface J. Immunol., April 1, 2009; 182(7): 4085 - 4092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Oliveira and P J Hansen Deviations in populations of peripheral blood mononuclear cells and endometrial macrophages in the cow during pregnancy Reproduction, October 1, 2008; 136(4): 481 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Amsalem, A. Gaiger, S. Mizrahi, S. Yagel, and J. Rachmilewitz Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua Int. Immunol., September 1, 2008; 20(9): 1147 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Taglauer, A. S. Trikhacheva, J. G. Slusser, and M. G. Petroff Expression and Function of PDCD1 at the Human Maternal-Fetal Interface Biol Reprod, September 1, 2008; 79(3): 562 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Abrahams, P. B. Aldo, S. P. Murphy, I. Visintin, K. Koga, G. Wilson, R. Romero, S. Sharma, and G. Mor TLR6 Modulates First Trimester Trophoblast Responses to Peptidoglycan J. Immunol., May 1, 2008; 180(9): 6035 - 6043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Koga and G. Mor Review Article: Expression and Function of Toll-Like Receptors at the Maternal--Fetal Interface Reproductive Sciences, March 1, 2008; 15(3): 231 - 242. [Abstract] [PDF]
|
|
|
|
 |
|
 W. V. Ingman and R. L. Jones Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology Hum. Reprod. Update, March 1, 2008; 14(2): 179 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. Lee, Y. Wang, B. S. Maciejewski, K. Esho, C. Fulton, S. Sharma, and J. Sanchez-Esteban Interleukin-10 protects cultured fetal rat type II epithelial cells from injury induced by mechanical stretch Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L225 - L232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pejcic-Karapetrovic, K. Gurnani, M. S. Russell, B. B. Finlay, S. Sad, and L. Krishnan Pregnancy Impairs the Innate Immune Resistance to Salmonella typhimurium Leading to Rapid Fatal Infection J. Immunol., November 1, 2007; 179(9): 6088 - 6096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Robertson, A. S. Care, and R. J. Skinner Interleukin 10 Regulates Inflammatory Cytokine Synthesis to Protect Against Lipopolysaccharide-Induced Abortion and Fetal Growth Restriction in Mice Biol Reprod, May 1, 2007; 76(5): 738 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Renaud, S. K. Macdonald-Goodfellow, and C. H. Graham Coordinated Regulation of Human Trophoblast Invasiveness by Macrophages and Interleukin 10 Biol Reprod, March 1, 2007; 76(3): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schmitz, E. Souil, R. Herve, C. Nicco, F. Batteux, G. Germain, D. Cabrol, D. Evain-Brion, M.-J. Leroy, and C. Mehats PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation J. Immunol., January 15, 2007; 178(2): 1115 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Robertson, R. J. Skinner, and A. S. Care Essential Role for IL-10 in Resistance to Lipopolysaccharide-Induced Preterm Labor in Mice J. Immunol., October 1, 2006; 177(7): 4888 - 4896. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
